Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Jill Roberts Center for Inflammatory Bowel Disease
Explore this Website
Home
About Us
Toggle About Us menu options
Clinical Staff
Research Staff
Contact Us
Newsworthy
Toggle Newsworthy menu options
News and Announcements
Patient Care
Toggle Patient Care menu options
Clinical Services
FAQs
For Your Visit
COVID-19 Information
Nutrition Science
Toggle Nutrition Science menu options
Nutrition FAQs
Food Intolerances
News in IBD Nutrition
Research and Clinical Trials
Toggle Research and Clinical Trials menu options
Clinical Trials
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Newsworthy
Patient Care
Nutrition Science
Research and Clinical Trials
Home
Publications
Publications
Clinical Trials
Publications
Publications
Found 11 results
Author
[
Title
]
Type
Year
Filters:
Keyword
is
Escherichia coli
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
5
Zhang S
,
Fu J
,
Dogan B
,
Scherl EJ
,
Simpson KW
. 2018.
5-Aminosalicylic acid downregulates the growth and virulence of Escherichia coli associated with IBD and colorectal cancer, and upregulates host anti-inflammatory activity.
.
J Antibiot (Tokyo). 71(11):950-961.
C
Baumgart M
,
Dogan B
,
Rishniw M
,
Weitzman G
,
Bosworth B
,
Yantiss R
,
Orsi RH
,
Wiedmann M
,
McDonough P
,
Kim SGuk
et al.
. 2007.
Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum.
.
ISME J. 1(5):403-18.
E
Dogan B
,
Belcher-Timme HFacey
,
Dogan EI
,
Jiang Z-D
,
Dupont HL
,
Snyder N
,
Yang S
,
Chandler B
,
Scherl EJ
,
Simpson KW
. 2018.
Evaluation of Escherichia coli pathotypes associated with irritable bowel syndrome.
.
FEMS Microbiol Lett. 365(22)
I
Viladomiu M
,
Kivolowitz C
,
Abdulhamid A
,
Dogan B
,
Victorio D
,
Castellanos JG
,
Woo V
,
Teng F
,
Tran NL
,
Sczesnak A
et al.
. 2017.
IgA-coated enriched in Crohn's disease spondyloarthritis promote T17-dependent inflammation.
.
Sci Transl Med. 9(376)
Craven M
,
Egan CE
,
Dowd SE
,
McDonough SP
,
Dogan B
,
Denkers EY
,
Bowman D
,
Scherl EJ
,
Simpson KW
. 2012.
Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn's disease.
.
PLoS One. 7(7):e41594.
Dogan B
,
Suzuki H
,
Herlekar D
,
R Sartor B
,
Campbell BJ
,
Roberts CL
,
Stewart K
,
Scherl EJ
,
Araz Y
,
Bitar PP
et al.
. 2014.
Inflammation-associated adherent-invasive Escherichia coli are enriched in pathways for use of propanediol and iron and M-cell translocation.
.
Inflamm Bowel Dis. 20(11):1919-32.
M
Dogan B
,
Scherl E
,
Bosworth B
,
Yantiss R
,
Altier C
,
McDonough PL
,
Jiang Z-D
,
Dupont HL
,
Garneau P
,
Harel J
et al.
. 2013.
Multidrug resistance is common in Escherichia coli associated with ileal Crohn's disease.
.
Inflamm Bowel Dis. 19(1):141-50.
O
Stathopoulos C
,
Li T
,
Longman R
,
Vothknecht UC
,
Becker HD
,
Ibba M
,
Söll D
. 2000.
One polypeptide with two aminoacyl-tRNA synthetase activities.
.
Science. 287(5452):479-82.
R
Dogan B
,
Fu J
,
Zhang S
,
Scherl EJ
,
Simpson KW
. 2018.
Rifaximin decreases virulence of Crohn's disease-associated Escherichia coli and epithelial inflammatory responses.
.
J Antibiot (Tokyo). 71(5):485-494.
Kothary V
,
Scherl EJ
,
Bosworth B
,
Jiang Z-D
,
Dupont HL
,
Harel J
,
Simpson KW
,
Dogan B
. 2013.
Rifaximin resistance in Escherichia coli associated with inflammatory bowel disease correlates with prior rifaximin use, mutations in rpoB, and activity of Phe-Arg-β-naphthylamide-inhibitable efflux pumps.
.
Antimicrob Agents Chemother. 57(2):811-7.
T
Zegarra-Ruiz DF
,
Kim DV
,
Norwood K
,
Kim M
,
Wu W-JH
,
Saldana-Morales FB
,
Hill AA
,
Majumdar S
,
Orozco S
,
Bell R
et al.
. 2021.
Thymic development of gut-microbiota-specific T cells.
.
Nature. 594(7863):413-417.